Occupation and tongue cancer in Nordic countries.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
29 Apr 2024
Historique:
received: 14 12 2023
accepted: 21 03 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 29 4 2024
Statut: epublish

Résumé

Almost 200,000 tongue cancers were diagnosed worldwide in 2020. The aim of this study was to describe occupational risk variation in this malignancy. The data are based on the Nordic Occupational Cancer (NOCCA) study containing 14.9 million people from the Nordic countries with 9020 tongue cancers diagnosed during 1961-2005. The standardized incidence ratio (SIR) of tongue cancer in each occupational category was calculated using national incidence rates as the reference. Among men, the incidence was statistically significantly elevated in waiters (SIR 4.36, 95% confidence interval (CI) 3.13--5.92), beverage workers (SIR 3.42, 95% CI 2.02-5.40), cooks and stewards (SIR 2.55, 95% CI 1.82-3.48), seamen (SIR 1.66, 95% CI 1.36-2.00), journalists (SIR 1.85, 95% CI 1.18-2.75), artistic workers (SIR 2.05, 95% CI 1.54-2.66), hairdressers (SIR 2.17, 95% CI 1.39-3.22), and economically inactive persons (SIR 1.57, 95% CI 1.42-1.73). Among women, the SIR was statistically significantly elevated only in waitresses (SIR 1.39, 95% CI 1.05-1.81). Statistically significant SIRs ≤ 0.63 were observed in male farmers, gardeners, forestry workers and teachers, and in female launderers. These findings may be related to consumption of alcohol and tobacco, but the effect of carcinogenic exposure from work cannot be excluded.

Identifiants

pubmed: 38685000
doi: 10.1186/s12903-024-04172-2
pii: 10.1186/s12903-024-04172-2
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

506

Informations de copyright

© 2024. The Author(s).

Références

Int J Cancer. 2004 Dec 20;112(6):1015-9
pubmed: 15386365
Addiction. 1995 Nov;90(11):1487-95
pubmed: 8528034
Head Neck. 2017 Feb;39(2):297-304
pubmed: 27696557
Acta Oncol. 2009;48(5):646-790
pubmed: 19925375
Otolaryngol Head Neck Surg. 2013 May;148(5):792-6
pubmed: 23396594
Asian Pac J Cancer Prev. 2014;15(5):2225-9
pubmed: 24716961
Acta Otolaryngol. 2012 May;132(5):552-7
pubmed: 22339663
Clin Exp Dent Res. 2021 Feb;7(1):70-77
pubmed: 33140903
Acta Med Iran. 2011;49(3):159-62
pubmed: 21681703
Indian J Cancer. 2016 Apr-Jun;53(2):244-251
pubmed: 28071620
Indian J Med Paediatr Oncol. 2017 Jan-Mar;38(1):44-50
pubmed: 28469336
J Appl Oral Sci. 2013 Sep-Oct;21(5):460-7
pubmed: 24212993
Scand J Public Health. 2012 Nov;40(7):591-5
pubmed: 22949388
Anticancer Res. 2018 Jun;38(6):3223-3229
pubmed: 29848669
Int J Cancer. 2018 Jan 1;142(1):18-22
pubmed: 28857160
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oral Oncol. 2001 Feb;37(2):153-8
pubmed: 11167142
Acta Oncol. 2018 Apr;57(4):541-551
pubmed: 29145765
Br J Cancer. 2015 Jul 14;113(2):321-6
pubmed: 26057450
IARC Monogr Eval Carcinog Risks Hum. 2010;99:1-658
pubmed: 21528837
Am J Clin Nutr. 2006 May;83(5):1126-34
pubmed: 16685056
Scand J Public Health. 2015 Mar;43(2):204-11
pubmed: 25564114
Scand J Public Health. 2010 Nov;38(7):724-30
pubmed: 20688793
Oral Oncol. 2017 Apr;67:146-152
pubmed: 28351569

Auteurs

Johanna Peltonen (J)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland. johanna.peltonen@helsinki.fi.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland. johanna.peltonen@helsinki.fi.

Rayan Nikkilä (R)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki, HUS Helsinki University Hospital, Helsinki, Finland.
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.

Ahmed Al-Samadi (A)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
Institute of Dentistry, School of Medicine, Faculty of Health Sciences, University of Eastern Finland , Kuopio, Finland.

Antti Mäkitie (A)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki, HUS Helsinki University Hospital, Helsinki, Finland.
Division of Ear, Nose, and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden.
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Jan Ivar Martinsen (JI)

The Cancer Registry of Norway at the Norwegian Institute of Public Health, Oslo, Norway.

Kristina Kjaerheim (K)

The Cancer Registry of Norway at the Norwegian Institute of Public Health, Oslo, Norway.

Elsebeth Lynge (E)

Zealand University Hospital, Nykøbing Falster, University of Copenhagen, Denmark, Copenhagen, Denmark.

Par Sparen (P)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Laufey Tryggvadottir (L)

Icelandic Cancer Registry, Reykjavik, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, Lyon, France.

Tuula Salo (T)

Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.

Eero Pukkala (E)

Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH